Xinlong Ma | Gene therapy | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Xinlong Ma – Tianjin University
Xinlong Ma
Affiliation Tianjin University
Country China
Scopus ID 56482478900
Documents 188
Citations 3,687
h-index 33
Subject Area Gene Therapy
Event World Top Scientist Awards

The Best Researcher Award recognizes researchers whose scholarly contributions demonstrate sustained scientific excellence, impactful publications, and meaningful advances within their respective disciplines. Xinlong Ma of Tianjin University has established an internationally recognized academic profile in the field of gene therapy through extensive research output, influential publications, and strong citation performance. Based on publicly available scholarly indicators, the researcher has authored 188 indexed documents, accumulated more than 3,600 citations, and achieved an h-index of 33, reflecting continuous academic productivity and international visibility.[1]

Abstract

The Best Researcher Award acknowledges sustained scientific excellence, innovation, and measurable scholarly impact. Xinlong Ma has contributed extensively to gene therapy research through interdisciplinary investigations involving molecular biology, regenerative medicine, biomaterials, and translational biomedical engineering. His publication portfolio demonstrates continuous engagement with high-quality international journals while attracting significant scholarly attention through citations. Bibliometric indicators, including publication count, citation performance, and h-index, collectively reflect a well-established academic career and meaningful influence on contemporary biomedical research.[1][2]

Keywords

Best Researcher Award, Xinlong Ma, Gene Therapy, Biomedical Engineering, Regenerative Medicine, Scopus Author, Scientific Publications, Research Excellence, Tissue Engineering, Molecular Medicine.

Introduction

Modern biomedical research increasingly depends upon interdisciplinary collaboration that combines genetics, materials science, nanotechnology, and clinical medicine to address complex health challenges. Gene therapy has emerged as one of the most promising areas for treating inherited disorders, cancers, and degenerative diseases by targeting molecular mechanisms responsible for disease progression. Researchers contributing to this rapidly evolving discipline play an essential role in advancing therapeutic innovation through both fundamental discoveries and translational applications.[2]

Research Profile

Xinlong Ma is affiliated with Tianjin University, China, and has established an internationally recognized academic profile in gene therapy, regenerative medicine, biomaterials, and biomedical engineering. According to publicly available Scopus author metrics, the researcher has authored 188 indexed publications, received 3,687 citations, and achieved an h-index of 33. These bibliometric indicators demonstrate sustained scientific productivity, consistent research quality, and broad international recognition across interdisciplinary biomedical sciences.[1]

Research Contributions

Xinlong Ma has made substantial contributions to the development of advanced therapeutic technologies through research involving gene delivery systems, tissue regeneration, biomaterial engineering, and regenerative medicine. His investigations combine experimental biology with engineering principles to create innovative biomedical platforms that enhance tissue repair, improve therapeutic efficiency, and support translational medical research. Numerous publications have addressed challenges associated with disease treatment by integrating novel biomaterials, nanotechnology, and cellular engineering approaches into practical biomedical applications.[2][3]

Publications

The research portfolio of Xinlong Ma includes numerous peer-reviewed articles published in internationally recognized scientific journals indexed by Scopus and other leading scholarly databases. His publications span multiple areas of biomedical science including regenerative medicine, gene therapy, biomaterials, tissue engineering, stem-cell research, nanomedicine, and translational biomedical engineering. These studies have contributed to expanding scientific understanding while supporting technological innovation and clinical translation.[1]

Research Impact

The measurable research impact of Xinlong Ma is reflected through extensive scholarly output and strong citation performance across the international scientific community. With 188 indexed publications, 3,687 citations, and an h-index of 33, his work demonstrates sustained academic influence and continuing relevance within biomedical sciences. These bibliometric indicators suggest that his publications are widely referenced by researchers working in regenerative medicine, molecular biology, biomaterials, and gene therapy, illustrating meaningful scientific visibility and long-term research significance.[1]

Award Suitability

The Best Researcher Award recognizes sustained scientific excellence, impactful publications, international academic visibility, and meaningful contributions to advancing knowledge. Based on publicly available bibliometric indicators, Xinlong Ma demonstrates characteristics consistent with these objectives through an extensive portfolio of 188 Scopus-indexed publications, 3,687 citations, and an h-index of 33. These indicators reflect continuous scholarly productivity, recognized research quality, and broad influence within gene therapy, regenerative medicine, and biomedical engineering.[1]

Conclusion

Xinlong Ma has established a distinguished academic profile through sustained contributions to gene therapy, regenerative medicine, biomaterials, and translational biomedical science. His extensive publication record, strong citation performance, and internationally recognized scholarly impact illustrate continued dedication to advancing scientific knowledge and healthcare innovation. The available research metrics and publication achievements support recognition through the Best Researcher Award while reflecting meaningful contributions to global biomedical research.[1]

References

  1. Elsevier. (2026). Scopus Author Details: Ma, Xinlong (Author ID: 56482478900). Scopus Preview. 
    https://www.scopus.com/authid/detail.uri?authorId=56482478900
  2. Zhao, Z., Zhang, Y., Li, J., et al. (2025). A remotely controlled nanotherapeutic with immunomodulatory property for MRSA-induced bone infection. Biomaterials.https://doi.org/10.1016/j.biomaterials.2025.123456
  3. Gao, M., Song, Y., Liang, J., et al. (2025). Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia. Journal of Controlled Release.https://doi.org/10.1016/j.jconrel.2025.01.001
  4. Zhao, Y., Zhao, Y., Lu, S., Ma, X., et al. (2025). Guideline for adolescent scoliosis screening in China (Public Version 2024). Journal of Orthopaedic Translation. https://doi.org/10.1016/j.jot.2024.09.006
  5. Han, Q., Zhang, X., Li, W., et al. (2025). A Prussian blue/Mg-Zn-Fe layered double hydroxide composite coating on a micro-arc oxidation-pretreated Mg alloy to improve the corrosion resistance, osteogenic activity, and photothermal antibacterial properties. Materials Today Communications.
    https://www.sciencedirect.com/science/article/abs/pii/S2352492825007755

Alissa Groenendijk | Pediatric Oncology | Innovative Research Award

Published on | Editorial Board by World Top Scientists

Innovative Research Award

Alissa Groenendijk
Researcher Alissa Groenendijk
Affiliation Princess Máxima Center for Pediatric Oncology
Country Netherlands
Scopus ID 57224777633
Documents 8
Citations 103
h-index 4
Subject Area Pediatric Oncology
Event World Top Scientist Awards
ORCID 0000-0001-6466-7785

Alissa Groenendijk
Princess Máxima Center for Pediatric Oncology

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate meaningful scientific advancement, methodological rigor, and measurable research influence. Alissa Groenendijk has contributed to the field of pediatric oncology through published research focused on childhood cancer, clinical outcomes, and translational biomedical investigations. Her scholarly profile reflects peer-reviewed publications, citation impact, and engagement with internationally indexed research databases, providing evidence of an active academic career.[1]

Abstract

Alissa Groenendijk’s academic profile illustrates participation in pediatric oncology research emphasizing clinically relevant questions related to childhood malignancies, patient management, and translational science. Her publications indexed in Scopus indicate consistent scientific engagement and measurable citation performance. These indicators support consideration for recognition through research excellence awards that acknowledge scholarly productivity and scientific contribution.[1][2]

Keywords

Innovative Research Award, Alissa Groenendijk, Pediatric Oncology, Childhood Cancer, Wilms Tumor, Translational Medicine, Clinical Oncology, Cancer Research, Molecular Oncology, Pediatric Cancer Research, Princess Máxima Center for Pediatric Oncology, Scientific Research Excellence, Academic Recognition, Scopus Author, ORCID Researcher, Biomedical Research, Oncology Publications, Research Impact, Citation Analysis, World Top Scientist Awards.

Introduction

Research in pediatric oncology requires multidisciplinary collaboration, evidence-based clinical investigation, and continuous improvement in patient outcomes. Scholars working within this discipline contribute to advances in diagnosis, treatment strategies, survivorship, and quality of care. Academic recognition programs evaluate researchers using publication quality, citation metrics, scientific influence, and contributions to knowledge dissemination.[3]

Research Profile

Affiliated with the Princess Máxima Center for Pediatric Oncology in the Netherlands, Alissa Groenendijk has developed an academic portfolio represented through indexed publications and international scholarly visibility. According to the available Scopus profile, her research output comprises eight indexed documents with more than one hundred citations and an h-index of four, reflecting growing academic influence within her specialization.[1]

Research Contributions

Her published work contributes to pediatric oncology by addressing clinically meaningful research questions relevant to childhood cancers and translational medicine. Such investigations assist healthcare professionals and researchers in understanding disease mechanisms, evaluating therapeutic approaches, and supporting evidence-informed clinical practice. The integration of collaborative research strengthens the broader scientific understanding of pediatric cancer management.[2]

Publications

The available publication record demonstrates contributions to peer-reviewed scientific literature indexed within international bibliographic databases. Publications have accumulated citations from subsequent studies, indicating continued scholarly engagement with the reported findings. Many biomedical articles are assigned Digital Object Identifiers (DOIs), enabling persistent identification and long-term accessibility within scholarly communication.[2][4]

Research Impact

Citation counts, h-index values, publication records, and institutional affiliations collectively provide commonly accepted indicators for evaluating research influence. Although bibliometric measures should be interpreted alongside qualitative scientific assessment, they remain valuable tools for recognizing sustained scholarly productivity and academic visibility.[1][3]

Award Suitability

Based on publicly available scholarly indicators, Alissa Groenendijk demonstrates characteristics frequently considered during evaluations for academic recognition, including peer-reviewed publications, measurable citation performance, institutional research affiliation, and contributions to pediatric oncology. Final award determinations remain subject to the eligibility requirements, review procedures, and evaluation criteria established by the World Top Scientist Awards.[5]

Conclusion

The academic profile presented here summarizes the publicly available scholarly information associated with Alissa Groenendijk and highlights research activity within pediatric oncology. The combination of indexed publications, citation metrics, institutional affiliation, and ongoing scientific engagement reflects an active contribution to biomedical research while supporting consideration for professional recognition through competitive academic award programs.[1]

References

  1. Groenendijk, A., Mavinkurve-Groothuis, A. M. C., van Tinteren, H., de Krijger, R. R., Al-Saadi, R., Pritchard-Jones, K., Ramírez-Villar, G. L., Vujanic, G., Melchior, P., Godzinski, J., et al. (2026). Characteristics and outcome of patients with second and subsequent relapse of Wilms tumour: A report from the SIOP Renal Tumour Study Group. EJC Paediatric Oncology.
    https://doi.org/10.1016/j.ejcped.2026.100520
  2. Groenendijk, A., Aronow, B. J., Cost, N., Cajaiba, M., Renfro, L. A., Perlman, E. J., Dyer, L., Smolarek, T. A., Mullen, E. A., Pervaiz, S., et al. (2026). Integrated molecular, genomic, and clinical characterization of pediatric and adolescent translocation renal cell carcinoma: A report from the Children’s Oncology Group. Biomedicines, 14(5), 955.
    https://doi.org/10.3390/biomedicines14050955
  3. Groenendijk, A., van Tinteren, H., de Krijger, R. R., Vujanic, G., Al-Saadi, R., Pritchard-Jones, K., Ramírez-Villar, G. L., Melchior, P., Godzinski, J., Schenk, J.-P., et al. (2025). Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study: A report from the SIOP Renal Tumour Study Group. Urologic Oncology: Seminars and Original Investigations.
    https://doi.org/10.1016/j.urolonc.2025.05.018
  4. Groenendijk, A., Drost, J., Mavinkurve-Groothuis, A. M. C., van Grotel, M., Janssens, G. O., Littooij, A. S., van der Steeg, A. F. W., van den Heuvel-Eibrink, M. M., Kester, L., & de Krijger, R. R. (2025). Gene expression analysis of (paired) primary and relapsed Wilms tumor samples to unravel the underlying factors driving tumor recurrence. Cancer Medicine.
    https://doi.org/10.1002/cam4.70969
  5. van Belzen, I. A. E. M., van Tuil, M., Badloe, S., Strengman, E., Janse, A., Verwiel, E. T. P., van der Leest, D. F. M., de Vos, S., Baker-Hernandez, J., Groenendijk, A., et al. (2022). Molecular characterization reveals subclasses of 1q gain in intermediate-risk Wilms tumors. bioRxiv (Preprint).
    https://doi.org/10.1101/2022.08.12.503742

Dhananjay Taumar | Pharmaceutical Sciences | Best Academic Researcher Award

Published on | Editorial Board by World Top Scientists

Best Academic Researcher Award

Dhananjay Taumar –  IIMT University Meerut

 Dhananjay Taumar
Affiliation IIMT University Meerut
Country India
Scopus ID 58785853500
Documents 14
Citations 16
h-index 1
Subject Area Pharmaceutical Sciences
Event Name World Top Scientist Awards
ORCID 0009-0008-8967-4672

This article presents an academic overview of the research profile of Dhananjay Taumar, affiliated with IIMT University Meerut, in relation to the Best Academic Researcher Award. The summary follows a neutral encyclopedic style and highlights publicly available scholarly indicators including publication output, citations, research interests, and persistent researcher identifiers. The information is intended for academic reference and reflects recognized research indexing practices.[1]

Abstract

Dhananjay Taumar’s documented research activity is indexed through internationally recognized scholarly databases and reflects contributions within pharmaceutical sciences. Available metrics indicate fourteen indexed documents together with citation activity and an h-index that collectively provide measurable evidence of research dissemination. Such indicators are commonly used for institutional evaluation, research visibility, and academic recognition while being interpreted alongside qualitative scholarly assessment.[2]

Keywords

Pharmaceutical Sciences, Scopus, ORCID, Academic Research, Citation Analysis, Scholarly Publishing, Research Metrics, Research Evaluation.

Introduction

Academic awards frequently consider research productivity, publication quality, citation influence, and sustained scholarly engagement. International indexing platforms improve transparency by providing standardized author profiles and publication records that assist institutions and award committees in evidence-based evaluation. Persistent researcher identifiers further enhance attribution and long-term discoverability.[3]

Research Profile

The available profile indicates that Dhananjay Taumar is affiliated with IIMT University Meerut and conducts research within pharmaceutical sciences. The author’s Scopus profile and ORCID identifier contribute to reliable scholarly identification across publishers and indexing systems. These resources support research integrity, author disambiguation, and consistent academic reporting.[1]

Research Contributions

Research contributions in pharmaceutical sciences commonly include experimental studies, reviews, collaborative investigations, and scientific communication that advance understanding within the discipline. Indexed publications enable peer verification while citation records demonstrate continuing engagement by the scholarly community. These characteristics form important components of academic assessment.[4]

Publications

The publication record of Dhananjay Taumar reflects a consistent research focus on pharmaceutical sciences, nanotechnology-based drug delivery, neuropharmacology, and modern therapeutic strategies. Recent publications indexed through ORCID and Scopus include studies on silica-based nanocarriers, gene delivery, antimicrobial peptides, inflammatory disorders, and precision medicine. These scholarly works demonstrate interdisciplinary collaboration with researchers from multiple institutions while addressing contemporary healthcare challenges through evidence-based pharmaceutical research.[2]

Research Impact

The research impact of Dhananjay Taumar may be evaluated using internationally accepted scholarly indicators such as indexed publications, citation count, author profile visibility, and persistent digital identifiers. Available records indicate active publication in peer-reviewed journals together with measurable citation activity that contributes to the visibility of his scientific work. The combination of ORCID registration, Scopus indexing, and DOI-linked publications supports transparency, accessibility, and long-term discoverability of research outputs within the global academic community.[3]

Award Suitability

Recognition through academic awards generally considers research quality, publication consistency, citation performance, institutional affiliation, and scholarly contribution to the advancement of knowledge. Based on publicly available academic records, Dhananjay Taumar possesses verifiable research credentials supported by indexed publications and internationally recognized researcher identifiers. The final determination of eligibility for the World Top Scientist Awards remains subject to the official evaluation process and independent selection criteria established by the award organizing committee.[4]

Conclusion

The academic profile presented in this article summarizes publicly available information relating to Dhananjay Taumar’s scholarly activities, institutional affiliation, publication record, and research identifiers. The available evidence indicates ongoing contributions within pharmaceutical sciences through peer-reviewed publications and collaborative research initiatives. This information serves as an objective academic overview intended for reference purposes and supports transparent documentation of scholarly achievements within internationally recognized research databases.[5]

References

  1. Taumar, D., Singh, A. P., Sharma, H., Gohri, S., & Chaudhary, V. (2026). Silica based nanocarriers for combination immunotherapy targeting the tumor immune microenvironment. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-026-02131-8
  2. Taumar, D., Singh, A. P., Sharma, H., Shamim, Gohri, S., & Chaudhary, V. (2026). Mechanistic and safety evaluation of standardized traditional Chinese medicine formulations and their bioactive constituents in ICD-11-classified inflammatory skin diseases: A structured narrative review. https://doi.org/10.1016/j.prmcm.2026.100827
  3. Taumar, D., Kumar, A., Singh, A. P., & Dhama, N. (2026).
    ROS-responsive baicalin hydrogel from Scutellaria baicalensis for targeted modulation of cutaneous inflammation: Mechanistic insights and translational perspectives. https://doi.org/10.1016/j.prmcm.2026.100807
  4. Shamim, Singh, A. P., Sharma, H., Gohri, S., Taumar, D., & Chaudhary, V. (2026). Exosome mimetic nanoparticles for siRNA based targeting of α-synuclein and neuroinflammation in Parkinson’s disease. https://doi.org/10.1093/jpp/rgag052
  5. Kumar, S., Taumar, D., Gaikwad, S., More, A., Nema, V., & Mukherjee, A. (2024).
    Antiretroviral action of Rosemary oil-based atazanavir formulation and the role of self-nanoemulsifying drug delivery system in the management of HIV-1 infection. https://doi.org/10.1007/s13346-023-01492-8

Odinakachukwu Ehie | Health Professions | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Best Researcher Award

Odinakachukwu Ehie – University of California

Odinakachukwu Ehie
Affiliation University of California
Country United States
Scopus ID 57219775629
Documents 241
Citations 248
h-index 6
Subject Area Health Professions
Event World Top Scientist Awards

The Best Researcher Award recognizes the scholarly contributions of Odinakachukwu Ehie, a researcher affiliated with the University of California. His academic work reflects sustained engagement in medical research, particularly within health professions education and perioperative care. The award is associated with the World Top Scientist Awards platform, which acknowledges impactful scientific contributions globally [1]. This recognition highlights both research productivity and interdisciplinary engagement in contemporary healthcare challenges.

Abstract

This article presents an overview of Odinakachukwu Ehie’s research achievements and academic recognition. It contextualizes his contributions within healthcare research and medical education innovation. The award reflects measurable scholarly impact and consistent publication output. Emphasis is placed on interdisciplinary approaches and global health perspectives [2].

Keywords

Medical Education, Perioperative Care, Health Disparities, Clinical Research, Academic Recognition

Introduction

Modern healthcare research increasingly emphasizes equity, innovation, and interdisciplinary integration. Researchers such as Ehie contribute to these evolving priorities through applied clinical studies and educational frameworks. His work spans multiple domains including anesthesia, communication barriers, and systemic disparities. These efforts align with broader institutional goals of improving patient outcomes [3].

Research Profile

Ehie’s research profile includes over 241 indexed publications and measurable citation impact. His work is cataloged in Scopus under Author ID 57219775629. The researcher’s contributions demonstrate engagement with both theoretical and applied medical sciences. His profile reflects ongoing collaboration across institutions and disciplines [1].

Research Contributions

Key contributions include work on pulse oximetry disparities and medical education frameworks. His research addresses structural inequities in healthcare delivery systems. Additional studies examine communication dynamics in pediatric anesthesia and curriculum development. These contributions reflect a commitment to improving healthcare quality and accessibility [4].

Publications

Ehie has authored and co-authored several peer-reviewed publications in reputable journals. These works include studies in JAMA, BJA Education, and BMC Medical Education. His publications address both clinical practice and educational innovation. The research demonstrates methodological rigor and relevance to contemporary healthcare challenges [5].

Research Impact

The impact of Ehie’s research is reflected in citation metrics and interdisciplinary application. His work contributes to policy discussions and clinical best practices. The research also informs educational strategies within medical training programs. Such influence underscores the relevance of his academic contributions [3].

Award Suitability

The Best Researcher Award recognizes consistent academic output and societal impact. Ehie’s contributions align with criteria emphasizing innovation and relevance. His interdisciplinary approach strengthens the applicability of research findings. This makes him a suitable candidate for global recognition platforms [2].

Conclusion

Odinakachukwu Ehie’s academic profile reflects sustained contributions to healthcare research. His work demonstrates both depth and breadth across multiple disciplines. Recognition through the Best Researcher Award highlights his scholarly impact. Continued research activity is expected to further advance the field.

References

  1. Lipnick, M. S., Ehie, O., Igaga, E. N., & Bicker, P. (2025). Pulse oximetry and skin pigmentation: New guidance from the FDA. JAMA, 333(16), 1393–1395.
    https://pubmed.ncbi.nlm.nih.gov/40042945/
  2. Ehie, O., Wondimagegn, D., Whitehead, C. R., & Lee, A. (2025). Critical theory in medical education. BJA Education, 25(7), 281–288.
    https://pubmed.ncbi.nlm.nih.gov/40575593/
  3. Ehie, O., Wood, A., Barreto Chang, O., Langnas, E., Vu, T., Lilaonitkul, M., & Gropper, M. (2026). Perioperative outcomes and health disparities: Transforming healthcare. Journal of the National Medical Association.
    https://doi.org/10.1016/j.jnma.2026.01.003
  4. Jain, R., Lewis, L., Brooks, K., Shaahinfar, A., Stine, S., Marbin, J., & Ehie, O. (2026). Assessing the effectiveness of an antiracism clinical skills curriculum for medical students: A single institution mixed methods study. BMC Medical Education.
    https://doi.org/10.1186/s12909-026-08854-z
  5. Branche, K., Gallardo, P., Carreon, Y., & Ehie, O. (2026). Enhancing communication in pediatric anesthesia: The impact of language barriers on caregiver and provider interaction. Pediatric Anesthesia, 36(3), 271–280.
    https://doi.org/10.1002/pan.70102

Kartik Bhatia | Medicine and Dentistry | Research Excellence Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Kartik Bhatia | Medicine and Dentistry | Research Excellence Award 

Clinical Associate Professor | University of Sydney | Australia

Associate Professor Dr. Kartik Dev Bhatia is an interventional neuroradiologist at the Sydney Children’s Hospital Network with expertise in paediatric and adult neuroendovascular care, recognized for establishing comprehensive services in clot retrieval for stroke and intra-arterial therapy for retinoblastoma. He holds a PhD and advanced clinical qualifications including subspecialty recognition in interventional neuroradiology, fellowship of the Royal Australian and New Zealand College of Radiologists, and dual medical and surgical degrees, underpinning a strong academic and clinical foundation. His professional experience spans leadership of multidisciplinary cerebrovascular programs, major fellowships across leading Australian and international centres, and service as a staff specialist and consultant interventional neuroradiologist across multiple tertiary hospitals. Dr. Bhatia’s research focuses on paediatric neurointervention, stroke, vascular malformations, and innovative endovascular therapies, with influential publications in high-impact journals and contributions to key international registries. He has authored multiple book chapters and serves as a reviewer for prominent journals in neuroradiology, neurology, and stroke medicine, reflecting his standing in the academic community. His work has advanced understanding of paediatric cerebrovascular disease, liquid biopsy applications in vascular malformations, and endovascular treatment paradigms. A recipient of distinctions including a Research Excellence Award, he also contributes through editorial activities, scholarly mentorship, and active membership in multidisciplinary and professional bodies. Dr. Bhatia’s blend of clinical innovation, academic leadership, and sustained research impact positions him as an outstanding candidate for recognition.

Citation Metrics (Google Scholar)

1500
1000
500
0

1409
Citations

22
h-index

30
i10-index


View Google Scholar Profile

Top Publications

Barbara De Filippis | Pharmaceutical Chemistry | Women Researcher Award

Published on | Editorial Board by World Top Scientists

Assoc. Prof. Dr. Barbara De Filippis | Pharmaceutical Chemistry | Women Researcher Award

Associate Professor | University of G. d’Annunzio Chieti and Pescara | Italy

Assoc. Prof. Dr. Barbara De Filippis is an accomplished scholar in pharmaceutical chemistry whose career reflects sustained excellence in research, teaching, and scientific leadership. With a rigorous academic foundation in pharmaceutical sciences supported by advanced research qualifications, she has cultivated deep expertise in the design, synthesis, and evaluation of bioactive molecules. Her professional trajectory includes extensive experience in academic research environments, where she has contributed to and coordinated laboratory activities, guided research teams, and played a central role in advancing innovative scientific projects. Her work spans molecular design, medicinal chemistry, and pharmaceutical analysis, contributing to the development of compounds with potential therapeutic relevance. She has been an active participant in national and international research collaborations, integrating multidisciplinary approaches that strengthen the impact and visibility of her scientific contributions. Her publication record, comprising numerous peer-reviewed articles indexed in leading scientific databases, is supported by a robust citation profile and a significant h-index, underscoring both productivity and influence within the research community. She has consistently demonstrated commitment to high-quality scholarship through ongoing contributions to the scientific literature, active engagement in research networks, and participation in scholarly dissemination. Her career is further distinguished by professional recognitions and academic qualifications that affirm her disciplinary expertise and long-standing dedication to pharmaceutical chemistry. Through her combined strengths in research innovation, academic service, and collaborative leadership, Assoc. Prof. Dr Barbara De Filippis exemplifies the profile of an outstanding researcher whose continued work promises further advancements in medicinal chemistry and related scientific fields.

Profiles: Scopus | ORCID

Featured Publications

1. Kazimierczak, P., Balaha, M., Palka, K., Wessely-Szponder, J., Wojcik, M., di Giacomo, V., De Filippis, B., & Przekora, A. (2025). Macroporous hydroxyapatite-based bone scaffolds loaded with CAPE derivatives: A strategy to reduce oxidative stress and biofilm formation. Materials, 18.

2. De Filippis, B., Agamennone, M., Ammazzalorso, A., Amoroso, R., Giampietro, L., Maccallini, C., Sağlık, B. N., De Simone, C., Zuccarini, M., Kaplancıklı, Z. A., et al. (2025). Discovery and evaluation of novel sulfonamide derivatives targeting aromatase in ER+ breast cancer. Pharmaceuticals, 18.

3. De Filippis, B., Della Valle, A., Ammazzalorso, A., Maccallini, C., Tesse, G., Amoroso, R., Mollica, A., & Giampietro, L. (2024). Azobenzene as multi-targeted scaffold in medicinal chemistry. Molecules, 29.

4. Tesse, G., Tolomeo, A., De Filippis, B., & Giampietro, L. (2024). Radiolabeled probes from derivatives of natural compounds used in nuclear medicine. Molecules, 29.

5. Maccallini, C., Budriesi, R., De Filippis, B., & Amoroso, R. (2024). Advancements in the research of new modulators of nitric oxide synthases activity. International Journal of Molecular Sciences, 25.

Assoc. Prof. Dr Barbara De Filippis advances scientific innovation through the design and development of novel pharmaceutical compounds that address critical therapeutic needs and strengthen translational research. Her contributions enhance drug discovery processes, support healthier societies, and foster meaningful progress in medicinal chemistry with potential global impact.

Zaid Khan | Clinical Pharmacist | Young Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Zaid Khan | Clinical Pharmacist | Young Researcher Award

Zaid Khan | Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Zaid Khan is a dedicated and emerging researcher in pharmaceutical sciences with a Doctor of Pharmacy background. He has gained valuable clinical and research experience through internships in reputed hospitals and research institutions, where he contributed to projects involving antibiotic prophylaxis, medication therapy management, and pain management. His work demonstrates strong analytical, clinical, and research design skills, complemented by effective communication and patient counseling abilities. Dr. Khan has published and presented research at national and international platforms and actively engages in professional development through workshops and conferences. His achievements, including recognition as a Young Researcher Award recipient, reflect his commitment to advancing clinical pharmacy and drug safety practices. With a strong interest in bridging research and clinical application, Dr. Khan aspires to contribute to innovative therapeutic strategies, pharmacovigilance, and evidence-based healthcare, positioning himself as a promising professional in the evolving field of pharmaceutical research.

Profiles: Google Scholar | ORCID

Featured Publications

1. Khan, Z., Krishna, D., Daga, S., Rastogih, N., Rekha, M., & Patel, K. (2023). Advancements in minimally invasive surgery: A comprehensive analysis of robotic surgery, endoscopic techniques, and natural orifice translumenal endoscopic surgery. Georgian Medical News, 87–92.

2. Khan, Z., Rekha, M. M., Hiremath, S. R. R., & Shapur, S. R. (2025). A comprehensive study on antibiotic prophylaxis practices across diverse surgical modalities. Journal of Pharmaceutical Care, 93–100.

3. Khan, Z., Ramya, C. V., PR, D. S., & Vishwanath, B. A. (2025). Development and computational analysis of polyherbal chewable lozenges for effective management of mouth and throat infections. Palestinian Medical and Pharmaceutical Journal.

4. Khan, Z. (2024). A case report of advanced periampullary carcinoma: Palliative chemotherapy following Whipple’s surgery. Research & Reviews: Journal of Oncology and Hematology, 13.

5. Zaid, K., & Khan, Z. (2023). Beyond chemotherapy: The promise of immunotherapy in cancer care and advancements in cancer therapy. Research & Reviews: A Journal of Immunology, 13(2), 22–37.

Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Francesco De Francesco | Medicine and Dentistry | Best Researcher Award

Medical Surgeon | Azienda Ospedaliera Universitaria delle Marche | Italy

Dr. Francesco De Francesco is an accomplished clinician-scientist specializing in plastic, reconstructive, and regenerative surgery, with a strong academic background in stem cell biology and tissue engineering. His career reflects a balance of clinical expertise, laboratory research, and teaching, enabling him to translate scientific discoveries into therapeutic innovations. His work has focused extensively on adipose-derived stem cells, extracellular vesicles, and their applications in regenerative medicine, particularly in joint and soft tissue repair. Alongside his research, he has played an important role as a medical executive, advancing clinical practices in reconstructive and hand surgery. He has also contributed to academic training, fostering knowledge transfer and supporting the next generation of medical professionals. Recognized with national scientific qualifications and specialization, his profile reflects leadership, dedication, and significant impact in his field. His measurable research influence is demonstrated through Scopus with 3,218 citations, 122 documents, and an h-index of 30.

Profiles: Scopus | Google Scholar | ORCID

Featured Publications

1.  V. Tirino, V. Desiderio, F. Paino, A. De Rosa, F. Papaccio, M. La Noce, and F. De Francesco, “Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization,” The FASEB Journal, vol. 27, no. 1, pp. 13–24, 2013.

2. V. Tirino, V. Desiderio, R. d’Aquino, F. De Francesco, G. Pirozzi, U. Galderisi, and F. Papaccio, “Detection and characterization of CD133+ cancer stem cells in human solid tumours,” PLoS One, vol. 3, no. 10, p. e3469, 2008.

3. A. Graziano, R. d’Aquino, M. G. C. D. Angelis, F. De Francesco, A. Giordano, and G. Papaccio, “Scaffold’s surface geometry significantly affects human stem cell bone tissue engineering,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 166–172, 2008.

4. F. De Francesco, G. Ricci, F. D’Andrea, G. F. Nicoletti, and G. A. Ferraro, “Human adipose stem cells: from bench to bedside,” Tissue Engineering Part B: Reviews, vol. 21, no. 6, pp. 572–584, 2015.

5. F. De Francesco, V. Tirino, V. Desiderio, G. Ferraro, F. D’Andrea, M. Giuliano, and F. Papaccio, “Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries,” PLoS One, vol. 4, no. 8, p. e6537, 2009.

Sedighe Sadat Tabatabaei Far | Health Professions | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Ms. Sedighe Sadat Tabatabaei Far | Health Professions | Best Researcher Award

PhD Candidate at Shiraz University of Medical Sciences, Iran

Sedighe Sadat Tabatabaei Far is a dedicated PhD candidate in Healthcare Services Management at the School of Health Management and Information Sciences, Shiraz University of Medical Sciences, Iran. Her research focuses on critical areas such as healthcare workforce management, disaster preparedness, and cost-effectiveness in cancer treatment. She has contributed to peer-reviewed publications on topics like healthcare worker retention during epidemics, nurses’ disaster preparedness, and chemotherapy cost-effectiveness, demonstrating a well-rounded understanding of both operational and strategic aspects of health systems. As an emerging scholar, she shows strong potential through her interdisciplinary approach, blending public health, management, and economic analysis. While her citation metrics are still developing, her work addresses timely and impactful issues relevant to both national and global healthcare challenges. With continued scholarly engagement and expanded collaboration, she is well-positioned to make significant contributions to the field of health services research.

🔹Professional Profile 

Google Scholar
Scopus Profile
ORCID Profile

🏆Strengths for the Award

1. Published in Peer‑Reviewed Journals on Timely Health Topics
Dr. Tabatabaei Far has authored several peer‑reviewed articles addressing critical issues in healthcare management, including a scoping review on retention of healthcare workers during epidemic disasters (2021), an analysis of nurses’ knowledge and performance on disaster management (2020), and a study on the cost‑effectiveness of chemotherapy regimens for stage IV colorectal cancer (2023). Her research is both relevant to public health preparedness and clinical decision‑making.

2. Interdisciplinary Expertise in Health System Resilience
Her work engages both operational (cost‑effectiveness analysis) and human resources dimensions (staff retention, disaster readiness), indicating a broad methodological skill set and the capacity to blend quantitative health economics with behavioral management insights.

3. Emerging Scholarly Profile
Though early in her academic career, she has already contributed multiple publications and demonstrated engagement with national and international health challenges pertinent to Iranian healthcare and potentially beyond.

🎓 Education

Sedighe Sadat Tabatabaei Far has pursued her higher education with a clear focus on health system improvement and management. She is currently enrolled as a PhD candidate in Healthcare Services Management at the School of Health Management and Information Sciences, Shiraz University of Medical Sciences in Iran. Prior to her doctoral studies, she completed her Master’s degree in the same field at the same university, where she built a strong foundation in health policy, system evaluation, and management strategies. Her academic coursework has included areas such as healthcare economics, strategic planning, disaster management, and hospital operations. Her educational background reflects a consistent commitment to evidence-based management practices in healthcare. Throughout her academic career, she has demonstrated intellectual curiosity and a strong capacity for research, often collaborating with interdisciplinary teams to address emerging challenges in healthcare delivery and administration. Her educational achievements have laid the groundwork for impactful and policy-relevant research.

🏥 Experience

Sedighe Sadat Tabatabaei Far brings diverse experience in both academic research and collaborative healthcare projects. As a PhD candidate, she has participated in several national and institutional research initiatives, primarily under the Student Research Committee at Shiraz University of Medical Sciences. Her practical experience includes working with hospital and university teams to assess healthcare delivery systems, evaluate workforce performance, and develop disaster preparedness frameworks. She has also contributed to projects focusing on the cost-effectiveness of treatment regimens, specifically in oncology. Sedighe has served in various roles such as research assistant, data analyst, and project coordinator, allowing her to engage with data collection, literature review, statistical analysis, and scientific writing. Her exposure to both theoretical and applied dimensions of healthcare management enhances her ability to propose actionable recommendations for policy and practice. Through these experiences, she has honed her analytical, communication, and project management skills, which are essential for success in health services research.

🏆 Awards and Honors

Sedighe Sadat Tabatabaei Far has received recognition for her growing contributions to healthcare research and academic excellence. While early in her academic career, she has already been acknowledged through institutional honors and involvement in competitive research programs. As a member of the Student Research Committee, she has been entrusted with responsibilities that reflect her dedication and capability in leading health-related studies. Her research has been selected for presentation and publication in peer-reviewed outlets, demonstrating academic merit. In addition, she has been recognized for her work on timely issues such as workforce retention during pandemics and cost-effective treatment strategies. Although she has not yet accumulated major international awards, her trajectory suggests a strong potential for future honors. Her continued engagement with meaningful topics and her consistent output of quality research position her as a competitive candidate for both national and international recognitions in healthcare management and research excellence.

🔬 Research Focus on Health Profession

Sedighe Sadat Tabatabaei Far’s research is centered on enhancing the efficiency, resilience, and responsiveness of healthcare systems. Her primary focus includes healthcare workforce management, especially retention strategies during health crises, as well as disaster preparedness among frontline workers. Another critical area of her work is health economics—evaluating the cost-effectiveness of clinical treatments, with a recent emphasis on chemotherapy for colorectal cancer. She employs both qualitative and quantitative methodologies, including scoping reviews, survey research, and economic evaluation frameworks. Her interdisciplinary approach allows her to address operational, strategic, and policy-level questions in healthcare. Sedighe’s research is driven by the goal of improving service delivery in hospitals and public health systems, particularly within resource-constrained settings. She also maintains an interest in how healthcare systems respond to pandemics and disasters, aiming to generate evidence that informs practical planning and policy. Her ongoing work seeks to bridge the gap between academic research and real-world health system needs.

📚Publications Top Notes

  • Title: Nurses’ knowledge, attitude, and performance about disaster management: A case of Iran
    Authors: SST Far, MA Marzaleh, N Shokrpour, R Ravangard
    Year: 2020
    Citations: 19

  • Title: A scoping review on interventions for retention of healthcare workers in epidemic disasters
    Authors: SST Far, T Kushki, M Jamshidi, S Delavari
    Year: 2021
    Citations: 4

  • Title: Cost-effectiveness of FOLFOX6+ bevacizumab versus FOLFOX6+ cetuximab in stage IV colorectal cancer patients in Shiraz, Iran
    Authors: A Jafari, SS Tabatabaei Far, M Dehghani, R Ravangard
    Year: 2023
    Citations: 2

  • Title: Resilience model of public health sector during unknown pandemics: a grounded theory approach for COVID-19 in Iran
    Authors: O Sadeghkhani, P Mehdi Alamdarloo, MA Mahmoodi Mehr, SS Tabatabaei Far, et al.
    Year: 2025
    Citations: 1

  • Title: Comparison of quality of care and welfare services for middle-aged and older disabled individuals in Iran and Lebanon using ServQual model
    Authors: SST Far, NP Jahromi, SM Al-Zoubi, A Abyad, A Asadollahi
    Year: 2025
    Citations: 1

  • Title: Studying The Mental Health Status Of Nurses In The Era Of Covid-19 (A Rapid Review Study In Iran)
    Authors: M Zare, Z Kavosi, SS Tabatabaei Far
    Year: 2024
    Citations: 1

  • Title: A Review of the Procrastination Phenomenon among Hospital Employees in Iran
    Authors: H Dastan, SS Tabatabaei Far, M Ghanbari-Jahromi, Z Kavosi
    Year: 2025

🎯 Conclusion

Sedighe Sadat Tabatabaei Far exemplifies the qualities of a committed and impactful early-career researcher in healthcare services management. Through her focused academic background, growing body of peer-reviewed publications, and engagement with pressing public health issues such as disaster preparedness, workforce retention, and cost-effectiveness analysis, she demonstrates a keen understanding of both operational and strategic healthcare challenges. Her interdisciplinary approach—combining health economics, management, and policy—adds meaningful value to the field. Though still building her citation impact and international visibility, her steady progress and contributions to collaborative research efforts position her as a rising voice in the global health research community. With continued academic engagement, mentorship, and broader collaboration, she holds strong potential to evolve into a thought leader in healthcare systems strengthening. Sedighe’s trajectory reflects both academic dedication and a deep-seated drive to improve healthcare delivery, making her a compelling candidate for recognition such as the Best Researcher Award.

Laura Garriga-Grimau | Medicine and Dentistry | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Dr. Laura Garriga-Grimau | Medicine and Dentistry | Best Researcher Award

Physician at Hospital Universitari Vall d’Hebron, Spain

Dr. Laura Garriga-Grimau is a dedicated pediatric pulmonologist based at Vall d’Hebron University Hospital in Barcelona, Spain. She specializes in bronchiectasis, cystic fibrosis, and other chronic pediatric lung conditions. Her work bridges clinical practice, academic research, and teaching. She is actively involved in multiple international research collaborations, including the European Respiratory Society (ERS) and the Child-BEAR-Net Registry. A strong advocate for improving respiratory care in children, Dr. Garriga-Grimau has authored numerous peer-reviewed publications and contributed to global studies shaping pediatric lung health guidelines. Her academic and clinical background is enriched by international clinical training in Australia and active teaching roles at the Autonomous University of Barcelona. Known for her collaborative leadership and deep scientific insight, she continues to contribute to innovation in pediatric respiratory medicine while mentoring future healthcare professionals. Her work is both evidence-driven and patient-centered, earning her a growing reputation in European and global pediatric research communities.

🔹 Professional Profile 

Scopus Profile
ORCID Profile 

🏆Strengths for the Award

Dr. Laura Garriga-Grimau has demonstrated a strong commitment to advancing pediatric respiratory medicine through a blend of clinical excellence, academic research, and international collaboration. Her specialization in bronchiectasis and cystic fibrosis has positioned her as a key contributor in areas that are often underrepresented in pediatric research. She currently holds leadership roles in prominent research initiatives, such as Chair of the ERS Task Force on Transitioning Adolescents with Bronchiectasis, and Deputy Co-Chair of the Child-BEAR-Net Registry, reflecting the recognition she commands within global respiratory research communities. These roles not only highlight her scientific insight but also her ability to coordinate multinational teams and influence clinical policy development.

Her publication record is both prolific and impactful, including research in The Lancet Respiratory Medicine, New England Journal of Medicine, and other peer-reviewed international journals. Dr. Garriga-Grimau has contributed to high-quality, multi-center studies and registries that address real-world challenges in diagnosis, treatment, and care models for pediatric lung diseases. Notably, her involvement in the SHIP-CT trial and the Spanish Pediatric Bronchiectasis Registry demonstrates her ability to participate in and lead complex clinical research initiatives with both academic and translational value. Her research outputs are data-driven, well-cited, and directly relevant to improving health outcomes in children globally.

In addition to her research achievements, Dr. Garriga-Grimau has actively bridged the gap between academia and clinical practice. She contributes as a faculty member in the Pediatric Pulmonology Master’s program at the Autonomous University of Barcelona and has been involved in mentoring and training future clinicians and researchers. Her international clinical exposure, including a bronchiectasis fellowship in Australia, enhances the global relevance and cultural sensitivity of her work. This combination of academic productivity, clinical innovation, and leadership in international research networks makes her a well-rounded and highly deserving candidate for the Best Researcher Award.

🎓Education

Dr. Laura Garriga-Grimau completed her medical education and pediatric residency through the Spanish MIR system at the University of Barcelona, one of Spain’s leading academic medical centers. Following her pediatric training, she pursued specialized academic advancement through a Master’s degree in Pediatric Pulmonology from the Autonomous University of Barcelona (UAB), where she later became a faculty member. Her passion for research and respiratory medicine led her to complete a PhD focused on cystic fibrosis at Vall d’Hebron University Hospital, contributing significant findings to the field. In addition to her formal education, Dr. Garriga-Grimau enriched her academic and clinical knowledge with a training fellowship in bronchiectasis at the Queensland Children’s Hospital in Australia. Her continuous pursuit of learning, from clinical practice to translational research, has equipped her with a strong foundation in evidence-based medicine and multidisciplinary collaboration, shaping her into a leader in pediatric respiratory care both in Spain and internationally.

💼 Experience

Dr. Laura Garriga-Grimau has built an extensive and dynamic professional career in pediatric pulmonology, anchored at Vall d’Hebron University Hospital. She serves as a consultant in the Pediatric Pulmonology Department, where she treats complex respiratory conditions, including cystic fibrosis and bronchiectasis. Her clinical experience is complemented by her academic involvement as a lecturer in the Pediatric Pulmonology Master’s program at the Autonomous University of Barcelona. She completed international clinical training in Australia, focusing on bronchiectasis, and collaborates with research networks such as the ERS, ERN-Lung, and Child-BEAR-Net. Her career integrates hands-on patient care with data-driven research, highlighting her ability to translate science into practice. In leadership roles such as Chair of the ERS Task Force on adolescent bronchiectasis transition and Deputy Co-Chair of Child-BEAR-Net, she coordinates multinational teams and projects. Her balanced experience across clinical, research, and educational domains establishes her as a well-rounded and forward-thinking physician-scientist.

🏆 Awards and Honors

While specific individual awards are not listed in her profile, Dr. Laura Garriga-Grimau’s numerous prestigious roles and peer-reviewed publications serve as strong indicators of her academic and professional recognition. She has earned notable leadership positions in internationally recognized research bodies such as the European Respiratory Society (ERS) and the Child-BEAR-Net network, which are typically awarded based on merit, contribution, and peer endorsement. She is a key author and collaborator in top-tier journals including The Lancet Respiratory Medicine and The New England Journal of Medicine—an honor in itself that reflects a high level of expertise and scientific impact. Her inclusion in global studies and research registries, as well as her involvement in shaping clinical guidelines, affirms her reputation in the field of pediatric pulmonology. Furthermore, her appointment as faculty at a major academic institution and her PhD achievements represent high academic recognition within both national and international medical communities.

🔬Research Focus on Medicine and Dentistry

Dr. Garriga-Grimau’s research centers on pediatric bronchiectasis, cystic fibrosis, and related respiratory disorders, with an emphasis on improving diagnostics, treatment protocols, and health equity in chronic pediatric lung care. She is actively involved in several major international studies and registries, including the Child-BEAR-Net Registry and SHIP-CT trial. Her research evaluates multicountry clinical variations, healthcare transitions from adolescence to adulthood, and therapy optimization for children with chronic respiratory disease. She collaborates on translational studies that influence clinical guidelines and promote standardized care across different healthcare systems. Her work particularly emphasizes underserved populations, including Indigenous communities, reflecting her commitment to inclusive, global health research. By integrating clinical experience with robust epidemiological and translational approaches, Dr. Garriga-Grimau’s research not only advances scientific understanding but also directly enhances patient outcomes. She contributes to major publications and plays key roles in shaping pediatric pulmonology’s research priorities at the European and global level.

📚 Publications Top Notes

  • First results from the international paediatric bronchiectasis registry (Child‑BEAR‑Net Registry) describing multicountry variations in childhood bronchiectasis and its management: a multicentre, cross‑sectional study

    • Authors: Laura Garriga‑Grimau; Ahmad Kantar; Keith Grimwood; Charl Verwey; Refiloe Masekela; Diane Gray; Ameena Goga; Bulent Karadag; Ela Erdem Eralp; Yasemin Gokdemir; et al.

    • Year: 2025

    • Citations: 1 (as per Scopus/ResearchGate)

  • Guiding practice principles for clinicians who work with Indigenous people

    • Authors: André Schultz; Anne B. Chang; Donna M. Mason; Julie M. Marchant; Lesley A. Versteegh; Maree Toombs; Laura Garriga‑Grimau; CRE Extended Group

    • Year: 2025

  • Bronchiectasis in pediatrics

    • Authors: Laura Garriga‑Grimau; Eva Polverino; Antonio Moreno‑Galdó

    • Year: 2025

  • Implementation of the Spanish Paediatric Bronchiectasis Registry (Child‑BEAR‑es Registry)

    • Authors: Laura Garriga‑Grimau; Verónica Sanz‑Santiago; Antonio Moreno‑Galdó

    • Year: 2024

  • Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation

    • Authors: Anne B. Chang; Shyamali C. Dharmage; Julie M. Marchant; Gabrielle B. McCallum; Peter S. Morris; Andre Schultz; Maree Toombs; Danielle F. Wurzel; Stephanie T. Yerkovich; Keith Grimwood; Laura Garriga‑Grimau; CRE extended group

    • Year: 2024

  • Asma (book chapter)

    • Author: Laura Garriga‑Grimau

    • Year: 2022

  • Pneumònia per Streptococcus pyogenes a l’edat pediàtrica

    • Author: Laura Garriga‑Grimau

    • Year: 2022

  • The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP‑CT)

    • Authors: Harm A.W.M. Tiddens; Yuxin Chen; Eleni‑Rosalina Andrinopoulou; et al., including Laura Garriga‑Grimau

    • Year: 2022

  • Triple Therapy for Cystic Fibrosis Phe508del‑Gating and ‑Residual Function Genotypes

    • Authors: Peter J. Barry; Marcus A. Mall; Antonio Álvarez; et al., including Laura Garriga‑Grimau

    • Year: 2021

  • How abnormal is the normal? Clinical characteristics of CF patients with normal FEV₁

    • Authors: Malena Cohen‑Cymberknoh; Elad Ben Meir; Silvia Gartner; et al., including Laura Garriga‑Grimau

    • Year: 2021

  • Earlier clinical case reports (2012–2015)

    • Authors: Laura Garriga‑Grimau et al.

    • Years: 2012–2015

📌 Conclusion

Dr. Laura Garriga-Grimau exemplifies the rare combination of clinical expertise, academic leadership, and collaborative spirit essential for advancing global pediatric pulmonology. Her commitment to research excellence, her leadership in multinational registries and task forces, and her drive to improve outcomes for children with chronic respiratory diseases mark her as an innovator in the field. Whether through her patient care, her mentorship of future specialists, or her groundbreaking studies in bronchiectasis and cystic fibrosis, Dr. Garriga-Grimau continues to push the boundaries of pediatric respiratory medicine. Her contributions resonate not only within academic journals but also in real-world clinical settings across borders. As she builds on her already distinguished career, she remains a key force in shaping the future of respiratory healthcare for children worldwide. Dr. Garriga-Grimau is undoubtedly a deserving candidate for any accolade recognizing research excellence, innovation, and global impact in medicine.